Jane Street Group, LLC Nls Pharmaceutics Ltd. Transaction History
Jane Street Group, LLC
- $88.2 Billion
- Q2 2024
A detailed history of Jane Street Group, LLC transactions in Nls Pharmaceutics Ltd. stock. As of the latest transaction made, Jane Street Group, LLC holds 43,672 shares of NLSP stock, worth $6,114. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,672Holding current value
$6,114% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NLSP
# of Institutions
11Shares Held
8.53MCall Options Held
0Put Options Held
0-
Bvf Inc San Francisco, CA5.75MShares$804,5970.04% of portfolio
-
Armistice Capital, LLC New York, NY2.31MShares$323,5400.01% of portfolio
-
Ubs Group Ag236KShares$33,0010.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il136KShares$19,0770.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny21.8KShares$3,0480.0% of portfolio
About NLS Pharmaceutics Ltd.
- Ticker NLSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,349,900
- Market Cap $4.11M
- Description
- NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, suc...